Quantitative urine proteomics in pregnant women for the identification of predictive biomarkers for preeclampsia

被引:0
作者
Sakari Joenväärä
Matilda Holm
Mayank Saraswat
Rahul Agarwal
Tiialotta Tohmola
Eero Kajantie
Katri Räikkönen
Hannele Laivuori
Pia M. Villa
Esa Hämäläinen
Risto Renkonen
机构
[1] University of Helsinki and Helsinki University Hospital,Transplantation laboratory, Faculty of Medicine
[2] Mayo Clinic,Present address: Department of Laboratory Medicine and Pathology
[3] All India Institute of Medical Sciences,Department of Reproductive Biology
[4] Finnish Institute for Health and Welfare,Children’s Hospital
[5] University of Helsinki and Helsinki University Hospital,PEDEGO Research Unit, MRC Oulu
[6] Oulu University Hospital and University of Oulu,Department of Psychology and Logopedics, Faculty of Medicine
[7] University of Helsinki and Helsinki University Hospital,Department of Obstetrics and Gynecology
[8] Tampere University Hospital,Faculty of Medicine and Health Technology
[9] Tampere University,Department of Medical and Clinical Genetics, Faculty of Medicine
[10] University of Helsinki and Helsinki University Hospital,Institute for Molecular Medicine Finland, Helsinki Institute of Life Science
[11] University of Helsinki,Department of Obstetrics and Gynecology
[12] University of Helsinki and Helsinki University Hospital,Hyvinkää Hospital
[13] Helsinki and Uusimaa Hospital District,Department of Clinical Chemistry
[14] University of Helsinki and Helsinki University Hospital,Department of Clinical Chemistry, Institute of Clinical Medicine
[15] University of Eastern Finland,undefined
[16] Kuopio University Hospital,undefined
关键词
Preeclampsia; Prediction; Biomarkers; Proteomics; Mass spectrometry; Urine;
D O I
10.1186/s41231-022-00108-6
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 121 条
  • [1] Lisonkova S(2013)Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease Am J Obstet Gynecol 209 544-644
  • [2] Joseph KS(2010)Pre-eclampsia Lancet 376 631-622
  • [3] Steegers EA(2017)Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia N Engl J Med 377 613-1798
  • [4] von Dadelszen P(2007)Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet. 369 1791-556
  • [5] Duvekot JJ(2012)Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis Am J Perinatol 29 551-33
  • [6] Pijnenborg R(2013)Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort BMC Pregnancy Childbirth 13 110-506
  • [7] Rolnik DL(2016)Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation Am J Obstet Gynecol 214 103-569
  • [8] Wright D(2019)The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention Int J Gynaecol Obstet 145 1-43
  • [9] Poon LC(2015)Urine proteomic studies in preeclampsia Proteomics Clin Appl 9 501-74
  • [10] O'Gorman N(2008)Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia Am J Obstet Gynecol 199 551-131g